Found 0 matching trials
Efficacy of NicVAX in Smokers Who Want to Quit Smoking
PHASE2The purpose of this study is to determine whether vaccination with NicVAX w...
Location
David Geffen School of Medicine at UCLA
A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
PHASE2The objective of this study is to assess the efficacy and safety of VitroGr...
Location
Multiple Locations
Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome
EARLY_PHASE1Study SYNB8802-CP-002 is designed to assess safety, tolerability, and oxala...
Location
PPD, part of Thermo Fisher Scientific
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
PHASE2This is a single center, randomized, blinded, placebo-controlled, two-perio...
Location
Royal Adelaide Hospital
A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
PHASE3The purpose of this study is to determine the efficacy of maternal immuniza...
Location
Research Site US115
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
PHASE2The objective of this trial is to assess the efficacy and safety of CNM-Au8...
Location
UT Southwestern Medical Center
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)
PHASE3The goal of this multi-center, randomized, double blind, placebo controlled...
Location
Optimal Research, LLC
A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)
PHASE3The Phase 3 study will use a novel randomized, intra-subject placebo-contro...
Location
Children's Hospital Oakland
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis
PHASE2The purpose of this study is to determine the effect of GBR 830 on biomarke...
Location
Glenmark Investigational Site 14
Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)
PHASE1This study is being performed to evaluate a single 60 Mcg dose of lyophiliz...
Location
Multiple Locations